On February 2nd, 2025, computer scientist and OpenAI co-founder Andrej Karpathy made a flippant tweet that launched a new phrase into the internet’s collective consciousness. He posted that he’d ...
When Sam Darnold threw his second interception Thursday night, there was no reason to believe the Seattle Seahawks could come back. The Los Angeles Rams had clearly been the better team. Darnold was ...
Of all the possible applications of generative AI, the value proposition of using it to write code was perhaps the clearest. Coding can be slow and it requires expertise, both of which can be ...
When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...
Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...
Developers are navigating confusing gaps between expectation and reality. So are the rest of us. Depending who you ask, AI-powered coding is either giving software developers an unprecedented ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback